Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
Clinical trial NCT06516887 · TERMINATED
Trial details
- NCT number
- NCT06516887
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-27
- Primary completion
- 2026-05-21
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.